TNF polymorphisms have been associated with susceptibility to malaria and other infectious and inflammatory conditions. We investigated a sample of 150 West African chromosomes to determine linkage disequilibrium (LD) between 25 SNP markers located in an 80 kb segment of the MHC Class III region encompassing TNF and eight neighbouring genes. We observed 45 haplotypes, and 22 of them comprise 80% of the sample. The pattern of LD is remarkably patchy, such that many markers show no LD with adjacent markers but high LD with markers that are much further away. We introduce a method of examining the implications of LD data for disease association studies based on sample size considerations: this shows that certain TNF polymorphisms would be likely to yield positive associations if the true disease allele resided in LTA or BAT1. We conclude that detailed marker maps are needed to resolve the causal origin of disease associations observed at the TNF locus.
Introduction
The central major histocompatibility complex (MHC) has a very high gene density, and a large proportion of these genes are predicted to have a role in immunity and inflammation. 1 This poses a considerable challenge for genetic association studies, because for a given disease there may be many plausible candidates in close physical and genetic proximity.
One candidate gene, TNF, has been associated with numerous infectious and inflammatory diseases. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] TNF is a proinflammatory cytokine that is an essential component of the immune response, but may be harmful in excess. Although there are no common polymorphisms in the amino-acid sequence of TNF, the gene promoter is rich with single nucleotide polymorphisms 13 (SNPs), some of which modify the expression of the TNF gene in vitro. 6, 14 Several of these promoter SNPs have been associated with susceptibility to infectious disease in Africa, raising the question of whether these are independent associations or whether they share a common etiology. 3, 6, 8, 9 A recent analysis of the TNF gene at the DNA sequence haplotype level found that many of the SNPs in TNF are inefficient markers of each otherFto such an extent that if one SNP in TNF were a true disease susceptibility locus, most of the other SNPs in TNF would appear neutral. 15 This suggests that the disease associations with TNF SNPs are independent of each other, but the possibility remains that an untyped SNP some distance away may be responsible for the observed associations with disease. It may be reasonable to expect that TNF SNPs, in weak linkage disequilibrium (LD) with each other, will also be in weak LD with more distant SNPs in the central MHC; however, the strength of LD is determined not only by the physical proximity of two mutations, but also by their proximity in time and lineage. 16 These factors are further modified by the effects of genetic drift, migration, and natural selection, and together they determine the pattern of LD in a population sample. 17, 18 So it is conceivable that TNF SNPs, while inefficient markers of each other, may be very good markers of SNPs in more distant genes. If such heterogeneity in LD existed, it would be important to account for it in the interpretation of disease association studies.
To begin to understand the relations between the SNPs in TNF and the SNPs in other genes of the central MHC, we focused on an 80 kb genomic segment containing nine genes, AIF1, NCR3, LST1, LTB, TNF, LTA, NFKBIL1, ATP6V1G2, and BAT1, each of which is involved in immunity or inflammation (see Table 1 and Figure 1 ). We developed a panel of 25 SNPs in six of these genes using DHPLC, DNA sequencing, and database interrogation. 13, 19 These 25 SNPs were genotyped in a sample of healthy Gambian adults to determine the haplotypic structure of this region. Analysis of this haplotypic structure reveals a heterogeneous pattern of allelic association between these genes of the central MHC.
Results
Haplotypic diversity A total of 25 SNPs in an 80 kb segment were genotyped in a sample of healthy Gambian adults. The sample of SNPs showed a broad range of allele frequencies ( Figure 2 ); those SNPs ascertained by database interrogation tended to be of greater frequency than SNPs ascertained by resequencing. These 25 SNPs describe 45 unique haplotypes ( Figure 3 ) and we estimate gene diversity, the chance that two randomly sampled haplotypes are different, to be 0.96 (s.d. ¼ 0.05). In Figure 4 , the cumulative haplotype frequencies are shown; 22 unique haplotypes are required to comprise 80% of the sample. Inspection of Figure 3 reveals that a few common SNPs dominate the haplotype structure, for example, the minor alleles of LTA*251 and BAT1*7126 occur together in a block found on about 40% of chromosomes. TNF*À308 occurs only on a subset of these chromosomes. Another common block of alleles is defined by BAT1*1595 and BAT1*1715 which tend to occur on the background of the NFKBIL1*15811 SNP. At the other end of the haplotype, some 60-80 kb away, AIF1*825, also a common SNP, exists on the background Figure 2 The distribution of SNP frequencies (with 95% confidence intervals) used in this study.
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Central MHC region flanking TNF HC Ackerman et al of both common haplotype blocks, strong evidence of recombination. In the intervening regions containing densely spaced markers in NCR3 and TNF, we see a number of rare haplotypes that are deeply divergent from the common haplotypes.
Dissecting the haplotypic structure
We applied the entropy maximization method (EMM) to identify those SNPs that most effectively dissect the underlying haplotypic structure of this 80 kb segment. The EMM searches for optimal combinations of SNPs that account for the greatest amount of haplotypic diversity as measured by entropy. In Figure 5 , we plot the percentage of the full 25-SNP haplotypic diversity that is accounted for by the optimal subset of SNPs, as the number of SNPs in the subset increases from 1 to 25. The single SNP that explains the greatest proportion of the full haplotypic diversity is LTA*251. Additional SNPs (indicated on the curve) are added, explaining increasing proportions of haplotypic diversity. The optimal seven-SNP subset explains greater than 80% of the full 25-SNP haplotypic diversity.
Pairwise correlations between SNPs
In order to quantify the correlations between allelic states in each pair of SNPs, we calculated r 2 from the haplotypic data ( Figure 6 ). The heterogeneity of allelic associations is evident. One would expect the strongest associations to be between those SNPs closest to each other, that is, along the diagonal of the figure. Only a few regions show strong correlations between adjacent SNPs: the five LTA, NFKBIL1, and BAT1 SNPs, and a few sets of three SNPs. We see predominantly weak associations punctuated by pockets of strong correlation, often between more distant SNPs. A small number of SNPs have significant correlations with many others. with little opportunity for recombination. TNF*À1031 and NCR3*3918 also have many significant correlations with other SNPs.
Pairwise power analysis LD or association statistics summarize a pairwise relation into a single statistic, when in fact there should be two, because the ability of SNP A to detect SNP B is not the same as the ability of SNP B to detect SNP A, unless they have the same frequency. Furthermore, the important role of allele frequency, which can (1) directly affect the measure of LD, (2) determine the power to reject LD, and (3) ultimately determine the power of an association study, is often unaccounted for. As an alternative to LD or association statistics, we propose using a different statistic, the power of a marker SNP to detect a hypothetical disease SNP. In calculating the power of one SNP to detect another, we can account for the strength of allelic association between a pair of SNPs, the frequencies of their alleles, and the asymmetry of their pairwise relation.
To construct the pairwise power map, we begin by assigning a hypothetical disease SNP a relative risk of 2. We then calculate the increased frequency of a marker allele, among cases drawn from the general population, by virtue of its association with the hypothetical disease SNP. The power to detect this change in allele frequency at the marker SNP is determined using a standard method. 20 We calculate power for all N Â N pairs of SNPs to generate the results shown in Figure 7 . Each row represents a marker SNP, and each column represents a hypothetical disease SNP. The power when the disease SNP itself is typed is found along the diagonal. The results in Figure 7 represent the power to detect an association at the Po0.01 level in 1000 cases and 1000 controls, when the hypothetical disease SNP in each pair is assigned a relative risk of 2.
In this sample of haplotypes, the prospect of detecting an association with a marker is bleak: many of the SNPs would be powerless to detect a relative risk (RR) of 2 at some other SNP in this region (average power to detect RR ¼ 2, Po0.01, in 1000 cases and 1000 controls is 16%, s.d. ¼ 28%); however, there are a few SNP pairs that are powerful enough markers of each other to be relevant to disease association studies. In this data set, allele frequency had only a moderate effect on the power of one SNP to detect a disease association at another SNP. The strong correlations between the LTA, NFKBIL1, and BAT1 SNPs, combined with their high frequencies, make these SNPs powerful but redundant markers of each other. Another cluster of powerful markers is found between NCR3*3008 and TNF*851. Outside of these two clusters, most SNPs would be powerless to detect a relative risk of 2 at their nearest neighbour. Moving away from the diagonal in Figure 7 , where the disease allele itself is typed, we see a few scattered marker-disease pairs of relevant power, an indication of the heterogeneity of allelic association in this region. A number of TNF promoter SNPs show moderate power to detect disease SNPs in the NCR3 promoter and 3 0 UTR even though they are powerless to detect associations at other SNPs in TNF. Finally, the TNF*À308 SNP, which has implicated the TNF gene in numerous diseases, is a powerful marker of SNPs in LTA, NFKBIL1, and BAT1 despite its low power to detect associations at other TNF promoter SNPs. 
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Haplotypes Defined Figure 5 Percentage of the 25-SNP haplotype diversity accounted for as the number of genotyped SNPs increases from 1 to 25.
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Discussion
We analysed 25 SNPs on 150 West African chromosomes to determine the haplotypic structure of an 80 kb segment of the central MHC flanking the TNF locus. We found 45 haplotypes, and a minimum of 22 different haplotypes were needed to comprise 80% of the sample. LD is remarkably heterogeneous, such that many markers show no LD with adjacent markers but high LD with markers that are further away. We describe these pairwise associations using a conventional measure of LD, r 2 , and introduce an alternative pairwise statistic, the power of a marker SNP to detect a given disease association at a hypothetical disease SNP. Our pairwise power map shows generally low power to detect associations with SNPs in this region, although some TNF polymorphisms would be likely to yield positive associations if the true disease allele resided in LTA or BAT1.
TNF associations
Polymorphisms in the TNF promoter have been associated with numerous infectious and inflammatory diseases. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In West African populations, the TNFÀ308 polymorphism has been associated with both trachoma and cerebral malaria; the TNFÀ238 polymorphism has been associated with severe malarial anaemia; and the TNFÀ376 has been associated with cerebral malaria. In both of these diseases TNF remains a strong candidate, but it is important to appreciate the potential involvement of other neighbouring genes, many of which could be strong candidates for disease association as well. We explored the hypothesis that disease associations with TNF SNPs could be attributed to SNPs in the genes flanking TNF, which were not typed in the association studies cited above.
Entropy maximization method
Haplotypic studies in the human genome have shown that, over short distances, alleles of SNPs tend to be correlated such that of the 2 n haplotypes possible with n SNPs, only a small fraction of them are actually observed. 21, 22 This is especially true among non-African populations, where SNP alleles are often found to occur together in blocks, a consequence of low haplotypic diversity.
23, 24 The observation that many of these SNPs are redundant markers of each other has inspired the development of methods for choosing a subset of SNPs that most efficiently distinguish the haplotypes in a population 15, 22, 25 . In this paper, we evaluate subsets of SNPs based on the proportion of the full haplotypic diversity that they explain. The measure of diversity we use is entropy, which is maximized when all haplotypes are of equal frequency. The application of this method allows us to choose the most informative SNPs even in the absence of a clear block-like haplotypic structure.
Not surprisingly, the single SNP with the greatest entropy is LTA*251, which has the greatest allele Central MHC region flanking TNF HC Ackerman et al frequency. The most informative pair of SNPs is created with the addition of AIF1*825, a common SNP that is not correlated with LTA*251 (r 2 ¼ 0.003). These two SNPs describe four haplotypes of moderate frequency (0.41, 0.30, 0.16, and 0.13) for a diversity that is about 40% of the full 25-SNP diversity. As more SNPs are included in the subset, the proportion of diversity explained increases. Interestingly, to generate the optimal six-SNP subset, the NKR3*3918 SNP is added, and the LTA*251 and BAT1*1715 SNPs are replaced by the TNF*À308 and BAT1*1595 SNPs. With the addition of NCR3*À412, 80% of the haplotypic diversity can be explained by seven SNPs. Efforts to choose SNPs that distinguish the common haplotypes at a gene locus represent a rational approach to reducing the number of SNPs genotyped in a disease association study. Unfortunately, dissecting the haplotypic structure does not ensure that the genotyped SNPs will be able to detect a disease-modifying SNP when one exists in the gene region. That ability is determined by the distribution of marker and disease alleles on the underlying haplotypic structure. To determine how well our haplotype-tagging SNPs would detect potential disease-modifying SNPs in the region flanking TNF, we examine the pairwise power map.
Pairwise power analysis
The first SNP chosen by the haplotype-based method was LTA*251. Fortunately, this SNP has moderate to high power to detect a relative risk of two at six other SNPs among the 25 analysed in this region. The addition of AIF1*825, an excellent haplotype-tagging SNP, does little to improve the power to detect an association at the other SNPs. The third haplotype-tagging SNP was NFKBIL1*15811; in terms of power to detect an association it is redundant: LTA*251 was already a good marker of those SNPs that NFKBIL1*15811 has power to detect. Likewise, BAT1*1715 and AIF1*206, priority haplotypetagging SNPs, contribute little additional power to detect associations caused by other SNPs in this region. The addition of NCR3*3918, which has power to detect associations at SNPs not covered by LTA*251, is the first haplotype-tagging SNP to improve the power to detect disease associations at other SNPs.
What combination of SNPs would provide good coverage as measured by statistical power to detect a disease association? By inspection of the pairwise power map in Figure 7 , the complementary combination of LTA*251, TNF*1304, and TNF*À863 together have moderate to high power to detect disease associations at 16/25 of the SNPs analysed in this region, including SNPs in every gene except AIF1. Interestingly, TNF*1304 and TNF*À863 have little utility in distinguishing the common haplotypes in this gene region and have low allele frequencies (0.07 and 0.04, respectively). These findings suggest that haplotype-tagging SNPs may not necessarily offer the best power to detect an association; it is important to consider the pairwise relations between SNPs when choosing markers for a disease association study.
The methods of entropy maximization and pairwise power mapping could be applied to data sets from other global populations. In non-African populations, we might expect to see lower haplotypic diversity and consequently more powerful relations between SNPs. While the detection of a disease association would be facilitated by more powerful relations between SNPs, this increased probability of detection would come at the cost of decreased resolution: it would be more difficult to identify the causal variant when many SNPs appear associated with disease. For example, a recent study in a Japanese population found SNPs in LST1, NCR3, LTB, TNF, LTA, NFKBIL1, ATP6VK, and BAT1 to be associated with susceptibility to myocardial infarction. 26 Functional data supported the notion that LTA*251 was the causal variant. Interestingly, even in the diverse West African population studied here, LTA*251 is in significant LD with SNPs in every gene studied. This makes it an excellent marker for the detection of disease associations in this region of the central MHC, and raises the question of what role LTA*251 has played in associations previously attributed to SNPs in neighbouring genes.
Possibility of selection
Under a neutral model of molecular evolution, highfrequency SNPs are expected to be old SNPs. In general, these older, high-frequency SNPs are expected to have lower LD with other SNPs, because there has been ample time for recombination events to restore linkage equilibrium between them. In contrast, under a scenario of natural selection, a favourable allele will rise in frequency over a relatively short period of time, and LD will persist. This may be the case with BAT1*7126 or LTA*251, which are high-frequency SNPs but are in significant LD with most of the SNPs analysed in this gene region. Closer examination of this gene region may reveal a signature of natural selection; 23, 27 if so, it would be interesting to determine whether the locus under selection is found among the classical HLA Class I/II loci, or whether a favourable variant exists in a gene of the central MHC.
Conclusion
We have generated a map of allelic association across an 80 kb segment of the central MHC. We find that allelic association is heterogeneous as a consequence of the complex haplotypic structure at this locus. This impression is confirmed by analysis of pairwise power which shows generally low power to detect disease-modifying SNPs even over short distances, punctuated by a few marker-disease SNP pairs with the power to detect associations over much greater distances. Interestingly, those SNPs that distinguish the common haplotypes of this region do not offer the best power to detect disease associations. While our analysis is limited to 80 kb, the heterogeneity of allelic association found thus far suggests that a comprehensive association map of the central MHC is required for the planning and interpretation of disease association studies in this region.
Methods

Subjects
Healthy unrelated adults were recruited in Banjul, The Gambia. All adults were parents of children who presented to hospital with severe malaria. A total of 55 family trios (mother, father, child), six parent-child pairs, and three adult singletons comprised the study sample. Since the healthy adults were parents of children with severe malaria, it was possible that the parents' transmitted chromosomes would have allele frequencies that differ from the general population. To test for this, we compared the allele frequencies of transmitted chromosomes against the allele frequencies of the untransmitted chromosomes and found them to be the same. We present data which include both transmitted and untransmitted chromosomes from the healthy unrelated parents. When available, the genotypes of offspring were used to help determine the phase of the parental haplotypes. The work was approved by the Gambia Government/Medical Research Council Joint Ethical Committee.
Ascertainment of SNP markers
A total of 10 SNPs in the TNF gene were previously identified by sequencing 36 healthy Gambians. 13 To these 10 SNPs we added one SNP in LTA, an NcoI RFLP 251 bp from the start of transcription. 28 Denaturing highperformance liquid chromatography and sequencing was used to identify five SNPs in NCR3, and two SNPs in AIF1 in 24 individuals of European descent. 19 Interrogation of NCBI's database, dbSNP, identified 45 potential SNPs in a 100 kb segment centred on TNF. Of these 45, 12 were selected for genotyping, but only seven of them appeared polymorphic. This contributed three more SNPs in NCR3, one SNP in NFKBIL1, and three SNPs in BAT1, for a total of 25 SNPs over 85 kb (median distance between SNPs: 384 bp).
Genotyping
The amplification refractory mutation system (ARMS) method was used to genotype SNPs. 13, 29 Primer sequences are given in Table 2 . PCR amplification was performed in a 15 ml reaction volume containing approximately 15 ng genomic DNA plus: 0.4 mM total dNTPs; 16.6 mM ammonium sulphate; 1.9 mM magnesium chloride; 67.9 mM Trisbase (pH 8. Table 2 as temperatures A and B, respectively. The accuracy of the ARMS PCR method was tested on sequenced individuals before extending it to DNA samples of unknown genotype.
Haplotype construction
Family and population data were integrated to generate the most certain haplotype reconstructions from genotypic data. This was implemented using the program PHAMILY to parse pedigrees for phase information before sending the genotypes to the program PHASE to reconstruct haplotypes. 30 Individuals with missing sites (because of genotyping failure) were not included in the analysis.
Haplotypic analysis Gene diversity. Gene diversity, the probability that two randomly sampled haplotypes will be different was calculated using
where n is the number of gene copies in the sample, k is the number of different haplotypes, and p is the frequency of the ith haplotype. 31 The sampling variance of this estimate was estimated using the method of Nei and Roychoudhury. 32 These calculations were performed using Arlequin. 33 Linkage disequilibrium. Pairwise LDs were calculated using the r 2 statistic. Terms for allele and two-locus haplotype frequencies are given in Table 3 . r 2 was calculated using
Entropy maximization method. A number of methods for selecting SNPs based on their ability to distinguish common haplotypes have been proposed. 15, 22, 23 Here we introduce a similar method that selects the subset of SNPs that accounts for the greatest proportion of the full haplotypic diversity at the locus of interest. We use entropy, E, as a measure of haplotypic diversity:
where p i is the frequency of the ith haplotype and there are k unique haplotypes in the sample. Entropy is maximized when all haplotypes have equal frequencies. Richard Mott designed an algorithm that identifies subsets of SNPs that dissect the haplotypes into groups approaching equal size, thus maximizing entropy. The entropy of these optimal subsets of SNPs (as the number of SNPs in the subset increases from 1 to 25) is plotted in Figure 5 .
Pairwise power map.
As an alternative to a LD or association statistic, we propose calculating the power of one SNP to detect an association at another SNP. Consider a true disease-modifying SNP A that is in LD with a neighbouring nonfunctional SNP B. The respective allele and haplotype frequencies are given in Table 3 .
In a random sample of the population, the frequency of SNP B, q 2 , is expected to be
We define R A as the relative risk associated with allele A 2 compared to allele A 1 . Under a multiplicative mode of inheritance, the frequencies of the different haplotypes found in diseased individuals are expected to be f 11 , f 12 , R A f 21 , and R A f 22 . Given the risk associated with A 2 and the frequency of each haplotype, we can Allele-specific atg ctg gaa ggt gaa tac aca Allele-specific TNF*467 ctc ttt ccc tga gtg tct tc Conserved A gtg cgc tga tag gga ggg Allele-specific gtg cgc tga tag gga gga Allele-specific TNF*À238 ggg gtc tgt gaa ttc ccg g Conserved A ccc cat cct ccc tgc tcc Allele-specific ccc cat cct ccc tgc tct Allele-specific TNF*À244 ggc tgg gtg tgc caa caa c Conserved A cca gaa gac ccc cct cg Allele-specific cca gaa gac ccc cct ca Allele-specific TNF*À308 ggc tgg gtg tgc caa caa c Conserved A ata ggt ttt gag ggg cat gg Allele-specific tag gtt ttg agg ggc atg a Allele-specific TNF*À376 ggc tgg gtg tgc caa caa c Conserved B cct gca tcc tgt ctg gaa g Allele-specific tcc tgc atc ctg tct gga aa Allele-specific TNF*À857 aag gat aag ggc tca gag ag Conserved B tct aca tgg ccc tgt ctt cg Allele-specific tct aca tgg ccc tgt ctt ca Allele-specific TNF*À863 ccg gga att cac aga ccc c Conserved B cga gta tgg gga ccc ccc Allele-specific gag tat ggg gac ccc ca Allele-specific TNF*À1031 ccg gga att cac aga ccc c Conserved B caa agg aga agc tga gaa gat Allele-specific caa agg aga agc tga gaa gac Allele-specific LT*251 gca ggt gag gct ctc ctg Conserved B gga agg gaa cag aga gga at Allele-specific gga agg gaa cag aga gga ac Allele-specific NFKBIL1*15811 gtc tca ttc ttg ggg ctt tg Conserved A gag att tag aac atc acg cac agt Allele-specific gag att tag aac atc acg cac agg Allele-specific BAT1*1595 gaa gcg ctc ata ttc ctt gc Conserved A tgg ggt tca tga ttt aga tTa cat Allele-specific tgg ggt tca tga ttt aga tTa cag Allele-specific BAT1*1715 acc ctt gac aac ctg aca gc Conserved A cga gtg tga cac atc aTc agt Allele-specific cga gtg tga cac atc aTc agc Allele-specific BAT1*7126 tct caa agg gag agc aag ga Conserved A tcc att gca gca ttc tga tct Allele-specific tcc att gca gca ttc tga tca Allele-specific derive the frequency of allele B 2 among diseased individuals (q 0 2 ):
We then calculate the power, the chance 1Àb of correctly declaring that the proportions q where a is the type I error rate or the significance level of the test,2 ¼ jq 2 þ q 0 2 j=2,1 ¼ 1 À q 2 , and N is the number of cases which is equal to the number of controls. The probability p associated with c 1Àb can be determined from p ¼ Pr(z4c 1Àb ), where z has the standard normal distribution. 
